Nutex Health, Inc. (NUTX) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $107.84. It has a SharesGrow Score of 77/100, indicating a strong investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of NUTX = $538.09 (+399% from the current price, the stock appears undervalued). Analyst consensus target is NUTX = $205 (+90.1% upside).
Valuation: NUTX trades at a trailing Price-to-Earnings (P/E) of 10.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.77.
Financials: revenue is $875M, +63%/yr average growth. Net income is $71M, growing at +113%/yr. Net profit margin is 8.1% (thin). Gross margin is 50.8% (+44.7 pp trend).
Balance sheet: total debt is $351M against $329M equity (Debt-to-Equity (D/E) ratio 1.07, moderate). Current ratio is 3.41 (strong liquidity). Debt-to-assets is 38.3%. Total assets: $919M.
Analyst outlook: 2 / 2 analysts rate NUTX as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 50/100 (Partial), Health 83/100 (Pass), Moat 64/100 (Partial), Future 100/100 (Pass), Income 45/100 (Partial).
